Evidence map›Paper›PMID 41633357›Full record

ArticleCell reports. Medicine2026

Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infections.

Luke B Snell, Suzanne Pickering, Adela Alcolea-Medina, Helena Winstone, Jeffrey Seow, Carl Graham, Lorcan O'Connell, Rahul Batra, Michael H Malim, Katie J Doores and 4 more

Abstract read
In one paragraph

Article in Cell reports. Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Luke B SnellDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK; Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Suzanne PickeringDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Adela Alcolea-MedinaDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK; Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Helena WinstoneDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Jeffrey SeowDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Carl GrahamDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Lorcan O'ConnellCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Rahul BatraCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Michael H MalimDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Katie J DooresDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Gaia NebbiaDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK; Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Jonathan D EdgeworthDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK; Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Stuart J D NeilDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Rui P GalãoDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Electronic address: rui_pedro.galao@kcl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evolution of SARS-CoV-2 in long-term persistent infections is hypothesized to be a major source of variants of concern (VOCs). However, linking intra-host variants into haplotypes that reflect viral subpopulations is limited by commonly used genomic sequencing techniques. We develop sequencing and analysis methods for identifying full-length spike haplotypes and analyze their diversification during persistent infections in individuals with inherited or acquired immunodeficiencies. This reveals accelerated evolutionary rates, with mutations frequently emerging at VOC-associated sites that confer escape from neutralizing antibodies, often undergoing strong positive selection. In a single infection lasting over 500 days from the first wave of the pandemic, we detail the evolution of spike as it acquires mechanisms to evade both autologous and heterologous neutralizing antibodies, redolent of Omicron variants. This evidence reinforces the argument for persistent infections being the source of immune-evasive variants, underscoring their impact on the evolutionary trajectory of SARS-CoV-2.

Indexed as

Antibodies, NeutralizingAntibodies, ViralCOVID-19Immune EvasionSARS-CoV-2Spike Glycoprotein, CoronavirusEvolution, MolecularHaplotypesHumansMutationAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2full-spike haplotypesimmune evasionpersistent infectionSARS-CoV-2variants of concern

Identifiers

PMID41633357
PMCPMC12923952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.